Atul Pande Immunovant, Inc. (IMVT) insider trading activity

Atul Pande is Director of Immunovant, Inc.. Currently has a direct ownership of 102,851 shares of IMVT, which is worth approximately $2.83 Million. The most recent transaction as insider was on Apr 01, 2025, when has been sold 16,188 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K

18.68% 3M change

8.94% 12M change

Total Value Held $2.83 Million

Atul Pande Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2025	BUY Grant, award, or other acquisition	-	16,188 Added 13.6%	102,851 Common Stock
Dec 02 2024	SELL Open market or private sale	$221,185 $28.54 p/Share	7,750 Reduced 8.21%	86,663 Common Stock
Apr 02 2024	BUY Grant, award, or other acquisition	-	11,255 Added 10.65%	94,413 Common Stock
Dec 01 2023	SELL Open market or private sale	$490,171 $39.69 p/Share	12,350 Reduced 12.93%	83,158 Common Stock
Apr 12 2023	BUY Grant, award, or other acquisition	-	12,523 Added 11.59%	95,508 Common Stock
Aug 17 2022	BUY Grant, award, or other acquisition	-	21,059 Added 20.24%	82,985 Common Stock
Jan 10 2022	BUY Grant, award, or other acquisition	-	21,726 Added 25.97%	61,926 Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	15,500 Added 27.83%	40,200 Common Stock

Also insider at

KRTX

Karuna Therapeutics, Inc. Healthcare

SIOX

Sio Gene Therapies Inc. Healthcare

Director

Atul Pande

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Value

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT

Account